Clinical Trial Update: A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability, and pharmacodynamics of SYNT-101 in healthy and overweight/obese adults; the study is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SYNT-101

Snippet

Sponsor: Syntis Bio | Conditions: Healthy, Overweight and Obese Adults | Phase 1 | Status: RECRUITING